Untreated T-cell Angioimmunoblastic Lymphoma
1 clinical trials · Condition
◉ Watch Untreated T-cell Angioimmunoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma (NCT00169156) | Lymphoma Study Association | 2005-12-01 |
Track Untreated T-cell Angioimmunoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.